Spending like a bigger company on purpose: current results carry the cost of an expansion aimed at demand management say
The model's full reasoning — Q3 2018 call → NO我们根据提供的财报电话会议记录,判断管理层是否承认当前业绩正受到已进行扩张的拖累,并且用已存在的需求来证明这种扩张的合理性。 首先,寻找关于扩张成本或负担的表述。在电话会议中,管理层多次提到投资于新产品、管线、国际扩张等。例如,David Meline提到“we continue incremental investments in our products and pipeline to drive growth”,以及“SG&A expenses increased 11%... driven by investments in product launches and marketed products support”。但这是否是“已进行的扩张”并“可见地拖累当前业绩”?管理层没有明确说这些投资正在压低当前利润或效率,而是说“we are encouraged by our strong results and earnings”以及“double-digit earnings per share growth”。他们提到“we continue to invest in our pipeline building out our global presence and increasing spend in support of long-term volume growth”,但并没有说这些投资正在“拖累”当前业绩,而是说“while delivering solid business performance”。所以,没有明确承认扩张成本正在压低当前结果。 其次,关于需求是否已经存在。管理层提到Aimovig的强劲启动,100,000名患者,以及“pent-up demand”等。但这是否是“已经存在的需求”来证明扩张?他们提到“we've been further energized by the remarkable response from physician and patient communities”,以及“over 100,000 patients starting Aimovig since launch”。这确实是实际需求。但扩张本身是否被描述为“已经进行并正在花费”?管理层没有具体说他们为了Aimovig或其他产品建立了新的设施或雇佣了大量人员,而是说“we continue to invest”和“we are excited about the opportunities”。他们提到“we've launched our first commercial biosimilar products in Europe”,但这是已经发生的,但并没有说这些扩张正在拖累当前业绩。 总体来看,管理层没有明确承认当前业绩被扩张所拖累,而是强调业绩强劲。他们也没有将扩张与当前业绩的负担联系起来。因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| LMAT | LeMaitre Vascular, Inc. | Q3 2021 | 2021-10-29 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| JBT | John Bean Technologies Corporation | Q2 2018 | 2018-07-26 | B |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
SIBN · Q3 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken — spending, hirin...YES Management explicitly describes the expansion as already underway and costing the company now: investments in sales force (85 territory managers + 72 specialists), new products (iFuse-TORQ, iFuse-Bedrock Granite), instrument trays, inventory, and R&D that are driving higher depreciation, freight, and product costs 84% gross margin (down low-single digits from these factors). Anshul confirms “we’ve made a substantial amount of investment whether it’s in TORQ trays or Granite trays or TORQ implants” and “this is going to lead to elevated depreciation,” while Laura notes the build supports “strong new product demand.
FLYW · Q1 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES The transcript shows management explicitly linking the current EBITDA decline to the hiring expansion already completed ("increased the number of FlyMates by over 50% during the past year" and "added over 100 new FlyMates within the sales, marketing and product functions"), while framing the spending as a deliberate, ongoing 2022 investment plan that is already delivering observable results through record client adds (130), pipeline growth, and strong ARR signings.
EVGO · Q2 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES Management describes concrete expansion already underway—170 stalls placed in Q2, total stalls at 2,397 with 460 under construction, pipeline at 3,669, CapEx jumped to $44 million to accelerate deployment, and G&A ramping personnel to support growth—while directly tying the resulting negative adjusted EBITDA of -$19.8 million to that deliberate build-out.